Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 508,824 | 249,380 | 204,036 | 180,080 | 793,735 |
| Cost of Goods | 20,163 | 12,796 | 26,761 | 25,735 | 425 |
| Gross Profit | 488,661 | 236,584 | 177,275 | 154,345 | 793,310 |
| Operating Expenses | 700,868 | 723,657 | 715,554 | 797,061 | 485,028 |
| Operating Income | -212,044 | -486,277 | -537,518 | -641,981 | 308,707 |
| Interest Expense | 28,151 | 18,793 | 16,767 | 0 | 0 |
| Other Income | 174,332 | -946 | 2,004 | 897 | 6,233 |
| Pre-tax Income | -65,863 | -506,016 | -552,281 | -641,084 | 314,940 |
| Income Tax | 1,226 | 968 | 5,236 | 3,001 | 1,058 |
| Net Income Continuous | -67,089 | -506,984 | -557,517 | -644,085 | 313,882 |
| Net Income | $-67,089 | $-506,984 | $-557,517 | $-644,085 | $313,882 |
| EPS Basic Total Ops | -1.07 | -8.37 | -9.35 | -11.01 | 5.76 |
| EPS Basic Continuous Ops | -1.07 | -8.37 | -9.35 | -11.01 | 5.76 |
| EPS Diluted Total Ops | -1.07 | -8.37 | -9.35 | -11.01 | 5.59 |
| EPS Diluted Continuous Ops | -1.07 | -8.37 | -9.35 | -11.01 | 5.59 |
| EPS Diluted Before Non-Recurring Items | -3.79 | -8.37 | -9.35 | -6.60 | 5.59 |
| EBITDA(a) | $-218,218 | $-492,078 | $-526,765 | $-634,141 | $315,732 |